within Pharmacolibrary.Drugs.ATC.H;

model H01AA02
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0011666666666666668,
    adminDuration  = 600,
    adminMass      = 250 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0004,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>H01AA02</td></tr><td>route:</td><td>intramuscular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tetracosactide, also known as cosyntropin, is a synthetic polypeptide that corresponds to the first 24 amino acids of adrenocorticotropic hormone (ACTH). It is primarily used as a diagnostic agent in the ACTH stimulation test to evaluate adrenal insufficiency by stimulating corticosteroid secretion from the adrenal cortex. It is approved and used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult volunteers after intramuscular administration.</p><h4>References</h4><ol><li><p>Wüthrich, P, et al., &amp; Buri, P (1994). Effect of formulation additives upon the intranasal bioavailability of a peptide drug: tetracosactide (ACTH1-24). <i>Pharmaceutical research</i> 11(2) 278–282. DOI:<a href=\"https://doi.org/10.1023/a:1018915710318\">10.1023/a:1018915710318</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8165188/\">https://pubmed.ncbi.nlm.nih.gov/8165188</a></p></li><li><p>Hawkins, JB, &amp; Burch, WM (1989). Rapid tests of adrenocortical function. Intravenous versus intramuscular administration of synthetic ACTH. <i>North Carolina medical journal</i> 50(6) 306–308. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2662018/\">https://pubmed.ncbi.nlm.nih.gov/2662018</a></p></li><li><p>Behrend, EN, et al., &amp; Lee, HP (2006). Intramuscular administration of a low dose of ACTH for ACTH stimulation testing in dogs. <i>Journal of the American Veterinary Medical Association</i> 229(4) 528–530. DOI:<a href=\"https://doi.org/10.2460/javma.229.4.528\">10.2460/javma.229.4.528</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16910850/\">https://pubmed.ncbi.nlm.nih.gov/16910850</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end H01AA02;
